Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.
Bouchahda M, Boige V, Smith D, Karaboué A, Ducreux M, Hebbar M, Lepère C, Focan C, Guimbaud R, Innominato P, Awad S, Carvalho C, Tumolo S, Truant S, De Baere T, Castaing D, Rougier P, Morère JF, Taieb J, Adam R, Lévi F; ARTBC International. Bouchahda M, et al. Among authors: rougier p. Eur J Cancer. 2016 Nov;68:163-172. doi: 10.1016/j.ejca.2016.09.011. Epub 2016 Oct 18. Eur J Cancer. 2016. PMID: 27768923
Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: feasibility and potential benefits in a retrospective series of 117 patients.
Bachet JB, Mitry E, Lièvre A, Lepère C, Vaillant JN, Declety G, Parlier H, Emile JF, Julié C, Rougier P. Bachet JB, et al. Among authors: rougier p. Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):1036-44. doi: 10.1016/j.gcb.2009.03.017. Epub 2009 Sep 15. Gastroenterol Clin Biol. 2009. PMID: 19758779 Free article.
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02).
Aparicio T, Lavau-Denes S, Phelip JM, Maillard E, Jouve JL, Gargot D, Gasmi M, Locher C, Adhoute X, Michel P, Khemissa F, Lecomte T, Provençal J, Breysacher G, Legoux JL, Lepère C, Charneau J, Cretin J, Chone L, Azzedine A, Bouché O, Sobhani I, Bedenne L, Mitry E; FFCD investigators. Aparicio T, et al. Ann Oncol. 2016 Jan;27(1):121-7. doi: 10.1093/annonc/mdv491. Epub 2015 Oct 20. Ann Oncol. 2016. PMID: 26487578 Free article. Clinical Trial.
Risk of venous thrombosis in patients with pancreatic adenocarcinoma.
Mitry E, Taleb-Fayad R, Deschamps A, Mansencal N, Lepère C, Declety G, Lièvre A, Vaillant JN, Lesur G, Cramer E, Dubourg O, Rougier P. Mitry E, et al. Among authors: rougier p. Gastroenterol Clin Biol. 2007 Dec;31(12):1139-42. doi: 10.1016/s0399-8320(07)78352-5. Gastroenterol Clin Biol. 2007. PMID: 18176374 Free article.
Chemosensitivity in ovarian metastases from gastric cancer: a case series.
Brieau B, Roussel H, Markoutsaki T, Dubreuil O, Trouilloud I, Landi B, Lepère C, Vaillant JN, Berger A, Rougier P, Taieb J, Zaanan A. Brieau B, et al. Among authors: rougier p. Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):289-95. doi: 10.1016/j.clinre.2012.09.007. Epub 2012 Nov 9. Clin Res Hepatol Gastroenterol. 2013. PMID: 23142590
598 results